Keros Therapeutics Inc (KROS) — Cash Flow Reinvestment Rate
Keros Therapeutics Inc (KROS) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting $264.00K (capex $132.00K plus investments $-132.00K) from operating cash flow of $3.25 Million. See Keros Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Keros Therapeutics Inc Cash Flow Reinvestment Rate (2018–2018)
Historical reinvestment intensity for Keros Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Keros Therapeutics Inc (KROS) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Keros Therapeutics Inc (2018–2018)
Year-by-year capital reinvestment analysis for Keros Therapeutics Inc. See how financially flexible is Keros Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.06x | $434.00K | $7.04 Million | $217.00K | — |